Results

Total Results: 2,612 records

Showing results for "included".

1961. Disposition of Comments for Technical Brief 25 Disparities within Serious Mental Illness (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
      May 26, 2016 - Our original literature search included the Mesh term “minority groups” as a way of capturing multiple … We have included a description of and a citation for the DECIDE study in the “Future Areas for Research … I like that you included total SMI population at 11 million. … This concern is included in the gaps GQ4 section on gaps in the evidence. … If an article was included by only one reviewer at full-text review, it was discussed by the reviewers

1962. Mrsa-Screening-2010 Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_executive.pdf
      January 01, 2010 - The review evaluated MRSA-screening strategies that included screening with or without isolation and … We included RCTs and nonrandomized comparative studies. … Quality of included studies was assessed using the U.S. … The 14 CCS studies17,18,20,21,23-32 that reported a healthcare-associated outcome were included in … The evidence base included an RCT of good quality, so the starting level for the SOE was high.

1963. Disposition of Comments Report for The Patient-Centered Medical Home (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-centered-medical-home_disposition-comments.pdf
      July 03, 2012 - Thank you for your comment concerning the logic of included studies. … It is unclear why this was not included. … We have included 1 additional study relevant to KQs 2-3. … The Pennsylvania demonstration project is included in KQ4. … This is a point that should be included in the discussion.

1964. Disposition of Comments Report for Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non-ST Elevation Myocardial Infarction (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
      January 01, 2014 - As you suggested, we have included these additional limitations. … They are not included in our report. … This reviewer’s niew is that they should not be included. … Why aren’t 30 day RCT results from Oasis 7 included? … This lack should be included in the section on research gaps.

1965. Disposition of Comments for CER 161 Major Depressive Disorder (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/major-depressive-disorder-disposition-160504.pdf
      December 08, 2015 - For treatment remission, only one of four included studies was from Germany. … That study was included in KQ 1b but mistakenly omitted from KQ 1a. … The evidence that was included was extremely complete. … Placebo-controlled studies were included in NWMAs. … The reviewer is correct, they were not included.

1966. Comparative Effectiveness of Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment–An Update to the 2006 Report | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/cancer-anemia-update/research-protocol

1967. Critical Analysis of the Evidence for Patient Safety Practices | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/patient-safety-practices/research-protocol

1968. Quantitative Synthesis: Learning Objectives and Recommendations (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-learning-objectives-recommendations.pdf
      July 01, 2019 - Quantitative Synthesis: Learning Objectives and Recommendations Quantitative Synthesis Learning Objectives and Recommendations Background • Purpose: ► To consolidate and update guidance from prior methods guides ► Focuses on Comparative Effectiveness Reviews (CERs): − Systematic reviews comparing effectiveness …

1969. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-treatment_research-protocol.pdf
      February 10, 2010 - Each article will be coded as: potentially included (I), excluded (E), or background (X). … Next, we will retrieve full- text articles for all potentially included studies, including those that … Authors of included studies will be contacted if clarification of methods (e.g., randomization methods … We will code the reasons that articles, at the stage of full review, are not included in the review. … In addition to describing these characteristics of the included trials, where data are sufficient we

1970. Masks-Appendix-Table-B-2-Version-2 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/masks-appendix-table-b-2-version-2.xlsx
      January 01, 2007 - who didn't wear mask, calculated OR with continuity correction 1.04 [0.05 to 19.52]) Mask use not included … 0.4 (0.2 to 0.9) • Always wore a mask when going out vs. never work a mask: OR 0.3 (0.1 to 0.6) Not included

1971. Appendix Table B-2. Observational Studies of Masks in the Community (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-2-version-1.xlsx
      January 01, 2007 - who didn't wear mask, calculated OR with continuity correction 1.04 [0.05 to 19.52]) Mask use not included … 0.4 (0.2 to 0.9) • Always wore a mask when going out vs. never work a mask: OR 0.3 (0.1 to 0.6) Not included

1972. Automated-Entry Patient-Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/health-data-mapping/report

1973. 1. What are the benefits and harms of rhythm control compared to rate control (including newer agents) ? What are the benefits and harms of strict vs more lenient rate control? 2. What are the benefits and harms of different… | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/get-involved/nominated-topics/1-what-are-the-benefits-and-harms-of-rhythm-control-compared-to-rate-control-including-newer-agents-what-are-the-benefits-and-harms-of-strict-vs-more-lenient-rate-control-2-what-are-the-benefits-and-harms-of-different-antico

1974. 1. For children with disruptive behavior disorders (DBDs), including Oppositional Defiant Disorder (ODD), Conduct disorder (CD), and Disruptive Behavior Disorder Not Otherwise Specified (DBD NOS), what is the short-term and long-term… | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/get-involved/nominated-topics/1-for-children-with-disruptive-behavior-disorders-dbds-including-oppositional-defiant-disorder-odd-conduct-disorder-cd-and-disruptive-behavior-disorder-not-otherwise-specified-dbd-nos-what-is-the-short-term-and-long-term-com

1975. A Prospective Comparison of Evidence Synthesis Search Strategies Developed With and Without Text-Mining Tools | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/research-strategies-text-mining-tools/methods-report

1976. Maternal and Child Outcomes Associated With the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/outcomes-nutrition/research

1977. Combination Therapy Versus Intensification of Statin Monotherapy: An Update | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/high-cholestorol-medicines-update/research

1978. AHRQ's Evidence-based Practice Center Division Annual Report 2021: Solving the Puzzle for Evidence-Based Decision Making (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2021.pdf
      January 01, 2021 - Topics discussed at the meeting included the new FDA framework for artificial intelligence and machine

1979. Slide 1 (ppt file)
      effectivehealthcare.ahrq.gov/sites/default/files/marketing_evidence_evans.ppt
      September 13, 2006 - Slide 1 Marketing “evidence” to healthcare consumers: Applying social marketing to evidence about the harms and benefits of pharmaceuticals Presented by W. Douglas Evans, Ph.D. Lauren McCormack, Ph.D., M.S.P.H Presented at Agency for Healthcare Research and Quality Conference: Communicating Harms and Benefits of …

1980. Layout 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_executive.pdf
      May 01, 2010 - Layout 1 Background Head and neck cancers, specifically those arising in the oral cavity, larynx, hypopharynx, oropharynx, nasopharynx, paranasal sinuses/nasal cavity, salivary glands, and occult primaries, account for approximately 3 to 5 percent of cancers in the United States. According to the National Comprehens…